TrimRx review
The compounded tiles name a mechanism rather than a drug, the bundle prices have gone behind a quiz, and the first-month discount lands on the same figure as the standing rate.
The verdict
TrimRx publishes $179 a month for its compounded GLP-1 line and $259 for the GLP-1 plus GIP line. The rate after the advertised first month is the same $179, and the site no longer sells any branded medication.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $179/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
TrimRx sells two compounded injections, labeled by receptor rather than by the molecule in the vial, with only the hero mockup naming tirzepatide. A patient prescribed a branded product fills it at a pharmacy of their own choosing.
Who writes the prescription, and what do they see?
A prescription precedes dispensing, but the pages describe products and tiers rather than the clinical relationship behind them.
Naming a product by its mechanism obstructs comparison shopping, because a reader who wants tirzepatide cannot find it from the tile, and the three bundle figures that once showed the term structure now sit behind a quiz.
What happens when the dose goes up?
The compounded rates are recorded as flat across doses, which is the answer a reader wants, though no milligram appears beside either tile to say what the flat rate is flat across.
What the price includes
Six months of the compounded GLP-1 line at $179 is $1,074, and the GLP-1 plus GIP line at $259 is $1,554. The struck-through $299 in the checkout mockup implies a first-month saving that the standing rate then erases, since $179 is what is charged either way.
What it claims, and what it cites
The two mechanism-named lines are compounded, prepared by a pharmacy the site does not name. The footer states that TrimRx does not sell, dispense or ship any branded medication, so a manufactured product is not an option here.
Where it holds up, and where it does not
- Strength: Compounded rates are stated flat across doses
- Strength: Both compounded lines carry a published rate
- Strength: The standing rate is not an introductory one
- Strength: The first-month figure matches what follows it
- Limitation: Products are named by mechanism rather than molecule
- Limitation: The three bundle prices are now quiz-gated
- Limitation: A strike-through implies a discount that does not persist
- Limitation: States served are not published
What the evidence says about this kind of treatment
The assessment above is about TrimRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who already knows which molecule they want and will read the hero mockup to find out which tile contains it.
- Wrong for
- A reader shopping by molecule name, or one hoping the struck-through figure means the first month costs less than the second.
The evidence behind what TrimRx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How TrimRx compares
| Seller | Who it suits | Go |
|---|---|---|
 ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
 NowPatient | Readers who want a named manufactured product and will read the buy box first | See NowPatient → |
 Navio MD | Readers who want the branded and compounded routes priced side by side | See Navio MD → |
More GLP-1 telehealth sellers reviews: HealthHubHealthicareHealthOnHealthSourceHeliMedsHello Alpha
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What is in the GLP-1 plus GIP line?
- Tirzepatide, according to the hero mockup on the homepage. The tile itself names only the mechanism, so the molecule appears nowhere a buyer would look first.
- Is $179 an introductory price?
- No. The checkout mockup strikes $299 through to $179 for a first month, and $179 is also the rate charged after it, so nothing changes at month two.
- Where did the bundle prices go?
- $316, $299 and $283 were published and are now reachable only by completing a quiz. That is a withdrawal rather than a change, and this site records it as one.
- Is TrimRx expensive compared with other GLP-1 telehealth sellers?
- TrimRx publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts TrimRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.